Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 204.50 |
|---|---|
| High | 206.70 |
| Low | 203.30 |
| Bid | 204.40 |
| Offer | 204.80 |
| Previous close | 206.30 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 70.35m |
| Free float | 70.15m |
| P/E (TTM) | 70.55 |
| Market cap | 17.10bn USD |
| EPS (TTM) | 3.45 USD |
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Press releases
- Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
- Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
- Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
- Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
- Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
- Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
- Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
More ▼
